Search Results

You searched for : Generics  

Takeda and Dr. Reddy’s Laboratories Enter into Exclusive Collaboration to Promote and Distribute QDENGA® in India’s Pediatric and Adult Private Market

Collaboration focuses on disease awareness, promotion and distribution of Takeda’s dengue vaccine, across India’s private market for pediatric and adult vaccination, ahead of ...
Sep 18

Why Local Medical Device Manufacturing Matters for Indian Healthcare

India imports nearly 70% of its medical devices, raising costs and limiting access. Local manufacturing through schemes like PLI can deliver affordable, resilient, and innovation-...
Sep 16

Dr. Reddy's Laboratories Launches Nationwide Educational Initiative to Strengthen India's Obesity Care Workforce

More than 5,000 healthcare support professionals to be trained to strengthen obesity prevention, education and long-term management across India Initiative aims to build ...
Sep 14

Dr. Reddy’s and Nestlé Health Science strengthens presence in diabetes & obesity nutrition space with Celevida® GLP+ launch

Dr. Reddy's and Nestlé Health Science Limited, a joint venture between Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; ...
May 07

BioAsia 2026 Positions Telangana as a Global TechBio Powerhouse

BioAsia, Asia’s premier life sciences and health-tech forum co-hosted by the Government of Telangana, is preparing to launch its 23rd edition on ...
Feb 14

Jubilant Pharmova – Q3 & 9M’FY26 results

On track towards Vision 2030 Solid revenue growth of 17% on the back of Line 3 in CDMO sterile Injectables EBITDA margins to expand going ...
Feb 06

A Trade Signature Away from Cheaper Medicines: Hope, Hype and Hard Truths

Over time, as competition increases and supply chains become more efficient, patients could experience tangible benefits, particularly in specialised care settings....
Jan 29

Why a Doctor’s Prescription Still Confuses Patients in 2026

As India continues to reform its medical education and regulatory systems, generic prescribing stands out as a test of sincerity....
Jan 15

Insulin Without Pain: Innovation or Illusion for India’s Diabetes Crisis?

A small inhaler may seem like a modest innovation, yet its implications reachs outward, touching behavior, psychology, and public health. ...
Dec 26

Behind Every Cheap Strip of Medicine Lies a Story No One Inspects

India can strengthen its position as the pharmacy of the world without losing the heart of its domestic ecosystem. But if the shift becomes a ...
Nov 15

The Slimmer Price War: How Wegovy’s Price Slash Signals a New Era in India’s Weight-Loss Drug Market

As the patent clock ticks towards 2026, both Novo and Lilly are likely to intensify their efforts in expanding supply chains, boosting physician engagement, and ...
Nov 14

Worms in Antibiotics, Deaths from Cough Syrup: Has India’s Medicine Safety Lost Its Pulse?

Regulatory bodies must act with transparency, manufacturers must uphold integrity, and hospitals must maintain vigilance because behind every batch number is a child whose life ...
Oct 18

Mankind’s Bet on Women’s Health: The ₹797-Crore Investment That Could Redefine India’s Pharma Future

In an industry where innovation often hides behind profit margins, Mankind’s bet on women’s health stands out as both a strategic and ethical ...
Oct 16

The Price of Healing: Will Lower GST on Medicines Truly Reach Patients Hands?

The GST reforms of September 2025 could become a landmark in the ongoing effort to make healthcare more affordable and accessible....
Sep 16

When Relief Turns Risk: How a Blood Pressure Pill Recall Exposed Gaps in Pharma Safety

Let it be a prompt to throttle up quality, not cut corners and to keep patient safety at centre, not supply speed....
Aug 18

Credibility Meets Convenience: India’s GLP-1 Battleground Gets a KwikPen Revolution

Long-term effects of GLP-1 medications remain under investigation, and shifting to easy-to-use pens removes barriers but not risks....
Aug 16

Breaking the Monopoly: Gland Pharma’s FDA-Cleared Injections Signal a New Era for Critical Care

FDA-approved injectables adds credibility in Africa, Latin America, and beyond. The ripple effect may elevate Indian pharmaceutical manufacturing from “copycat” to “crown-standard.”...
Aug 16

Can India’s Generics Take the Centre Stage and End Weight-Loss Monopoly

Generic semaglutide could ultimately become not just an alternative, but the new standard driven by precision manufacturing, scaled access, and cost redefined....
Aug 11

When Cheap Pills Turn Costly: How Tariff Threats May Topple India’s Pharma Powerhouse

India’s pharma strength was born of volume, value, and virtue. It supplied essential drugs when others hesitated and that legacy remains potent....
Aug 11

When Free Isn’t Felt: The Shadow Politics of Cutting Jan Aushadhi Out of Karnataka Hospitals

States like Tamil Nadu show how bulk procurement and coordinated public pharmacy systems outperform piecemeal outlets....
Aug 11

Why Branded Isn't Always Better: Indian Patients Are Dumping Brands for Generics

As more citizens choose affordability without compromising effectiveness, a stronger, healthier India begins to take shape....
Aug 06

India’s Weight Loss Gamble: Will GLP‑1 Drugs Reshape the Health of a Nation?

India is stepping into a new phase of healthcare where the battle against obesity is no longer limited to gym memberships or diet fads....
Aug 01

CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets

China Medical System Holdings Limited on the Main Board of the Singapore Exchange ("SGX"), SGX and CMS co-hosted the "Singapore and Emerging Markets Pharmaceutical ...
Jul 22

Wegovy Lands in India: Miracle Weight Loss Shot or Medical Marketing Hype?

As India confronts an alarming rise in obesity and related conditions like type 2 diabetes, cardiovascular disease, and polycystic ovarian syndrome, the spotlight on medical ...
Jun 25

Indian Innovation vs Western Monopolies: Lupin’s FDA Triumph Tells a Bigger Story

Rivaroxaban under a generic label can significantly reduce treatment costs for patients, insurers, and government healthcare programs, all while maintaining the efficacy and safety standards ...
Jun 03

25 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026